Mark Jit is professor and chair of the Department of Global and Environmental Health at New York University. He also holds honorary appointments at the London School of Hygiene & Tropical Medicine, the University of Hong Kong and the National University of Singapore. His research focuses on epidemiological and economic modelling of vaccines to support evidence-based public health decision making.
Associate Professor Natalie Carvalho is Head of the Economics of Global Health and Infectious Diseases Unit in the Centre for Health Policy, Melbourne School of Population and Global Health (MSPGH), University of Melbourne. Her work focuses on methodological advancements for, and application of, economic evaluation as one input for equitable and efficient decision-making on new interventions, with a particular focus on vaccines and other interventions targeting communicable and neglected tropical diseases. She coordinates the Health Economics & Economic Evaluation Specialisation within the Master of Public Health (MPH) at MSPGH and teaches Introduction to Economic Evaluation. She convenes a Special Interest Group on the Economics of Infectious Diseases through the Australian Health Economics Society.
Dr. Palwasha Anwari, Health Economics Consultant at WHO-EMRO, holds a DrPH from the London School of Hygiene and Tropical Medicine. Her work focuses on benefit-risk assessment, cost-utility analysis, and vaccine effectiveness. She supports EMRO Member States in generating economic evidence for immunization policy, including cost estimates for National Immunization Strategies, budgeting, and expenditure tracking.
Take a look at the agenda, speakers, and presentations by clicking the button below.